EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS129-13721 
Organism
Homo sapiens 
Tissue/cell
MCF10A 
Coordinate
chr16:1920190-1921220 
Target genes
Number: 56             
NameEnsembl ID
UBE2IENSG00000103275
C16orf42ENSG00000007520
GNPTGENSG00000090581
UNKLENSG00000059145
C16orf91ENSG00000174109
CCDC154ENSG00000197599
LA16cENSG00000261641
CLCN7ENSG00000103249
TELO2ENSG00000100726
IFT140ENSG00000187535
CRAMP1LENSG00000007545
HN1LENSG00000206053
MAPK8IP3ENSG00000138834
NME3ENSG00000103024
MRPS34ENSG00000074071
EME2ENSG00000197774
SPSB3ENSG00000162032
NUBP2ENSG00000095906
IGFALSENSG00000099769
FAHD1ENSG00000180185
HAGHENSG00000063854
SNORA10ENSG00000206811
SNORA64ENSG00000207405
AC005363.9ENSG00000255513
RPS2ENSG00000140988
SNHG9ENSG00000255198
SNORA78ENSG00000238671
RNF151ENSG00000179580
TBL3ENSG00000183751
NOXO1ENSG00000196408
GFERENSG00000127554
SYNGR3ENSG00000127561
AC005606.14ENSG00000261790
AC005606.15ENSG00000260107
ZNF598ENSG00000167962
NPWENSG00000183971
SLC9A3R2ENSG00000065054
TSC2ENSG00000103197
NTHL1ENSG00000065057
RP11ENSG00000259933
PKD1ENSG00000008710
RAB26ENSG00000167964
TRAF7ENSG00000131653
MLST8ENSG00000167965
C16orf79ENSG00000182685
PGPENSG00000184207
E4F1ENSG00000167967
DNASE1L2ENSG00000167968
ECI1ENSG00000167969
AC009065.1ENSG00000167970
RNPS1ENSG00000205937
ABCA3ENSG00000167972
C16orf59ENSG00000162062
TBC1D24ENSG00000162065
ATP6V0CENSG00000185883
AMDHD2ENSG00000162066
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr1619204051920505
chr1619206221921174
chr1619202741920324
Number: 1             
IDChromosomeStartEnd
GH16I001870chr1619203011921208
Enhancer Sequence
TAAACACACC TCTACATAGT AAAACTACAT GAGGGCAGAG GTGGCATCTT ACGTATTTTT 60
ATGTATGTAT TTCATAACTG AAAACCATAA ATATCAGATG AACGAAATGG TGGTTTGTCC 120
CTCAACATCA TCACTCTAAA AGGTTCTATT GTAGAAAAAT TGTAAGCTAC ACCAAACAGA 180
TTGACTTCAC TTTATAATCC AGGGCCTCTT TAACTCTGGG AATGCCCACA CCCACCCGCT 240
CCAGTTCAAG GACGTGTCTC ATGACACCTG AATTTCAGGC AGCCTGTGGA GTTAGTCAAA 300
TATGATTTTG AATTGCAACA CCACTAGTTT GTAGTCGTGT GTTTTAACAT TACTAAACAT 360
TAATTTCCTC ATCCTTAAAT TGTGGATAAC ATCCACCTGG CAGTGAAAAG TAGAAACAGT 420
GTATACAAGA TGCCTCGATG TTCACAGGCT CACAGTCAAT GATGGCCCTG CTTGTCAATA 480
TTATCCAATG TACCAGTTTT TGTATTCAAG GCCTTTCAGT GCCAGAAGAA ACATTTGGGA 540
ATTAAGCTGT GTCAAGTTTT TCATTCGTTC TTTGGCCTGG TCTGATGTGG CTCACAATGC 600
AGTGTCACTA TCTAAAACAC TTGCCGAACT GTGACAAATT CATTCACTCA TTCAACCATT 660
CAACTAATAT TTATTTACAG CCCAAAGTGC CAGACATGTG AGTCGAGAGG ATGAGTCAGA 720
CATTTGACTC AGTGGCTGAA TATTCTGTAC AAACACAACT ACCTACACAC CAAGGGATTT 780
CTCCACATTT TTACCCCTTA GCATCTCTTG GTGGGACATG GTATCCTATT ATCTCTCTGA 840
ATTCCCTTAT TTGTCTGCTA CCGTTAGAGG TATATGGTAA TAGACGTTAG TGTCTGCCCA 900
CAAAAAATAT GACTTGCTTC TCTACCTGGT CACTTTAACA GATACAAAAT TAACATGAAC 960
TAAAGAGCTC AATCTGAGAA TTCAGAGATG ACTTCATTCA ACAACTACTG TCTCTTTTAC 1020
CCTACAATTT 1030